GR3020155T3 - Substituted benzofuranyl-piperidine as nootropic - Google Patents
Substituted benzofuranyl-piperidine as nootropicInfo
- Publication number
- GR3020155T3 GR3020155T3 GR960401246T GR960401246T GR3020155T3 GR 3020155 T3 GR3020155 T3 GR 3020155T3 GR 960401246 T GR960401246 T GR 960401246T GR 960401246 T GR960401246 T GR 960401246T GR 3020155 T3 GR3020155 T3 GR 3020155T3
- Authority
- GR
- Greece
- Prior art keywords
- piperidine
- nootropic
- substituted benzofuranyl
- treatment
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH47091 | 1991-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3020155T3 true GR3020155T3 (en) | 1996-09-30 |
Family
ID=4187740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960401246T GR3020155T3 (en) | 1991-02-15 | 1996-06-06 | Substituted benzofuranyl-piperidine as nootropic |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0499586B1 (el) |
JP (1) | JPH0570352A (el) |
KR (1) | KR920016098A (el) |
AT (1) | ATE138805T1 (el) |
AU (1) | AU655227B2 (el) |
CA (1) | CA2061015A1 (el) |
DE (1) | DE59206442D1 (el) |
DK (1) | DK0499586T3 (el) |
ES (1) | ES2087497T3 (el) |
GR (1) | GR3020155T3 (el) |
IE (1) | IE74906B1 (el) |
IL (1) | IL100889A (el) |
MX (1) | MX9200620A (el) |
NO (1) | NO179358C (el) |
NZ (1) | NZ241608A (el) |
ZA (1) | ZA921091B (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3595093A (en) * | 1992-02-21 | 1993-09-13 | Ciba-Geigy Ag | Brofaromine as an agent for treating social phobia |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0386117B1 (en) * | 1987-10-22 | 1999-01-07 | Massachusetts Institute Of Technology | Treating premenstrual or late luteal phase syndrome |
-
1992
- 1992-02-06 IL IL100889A patent/IL100889A/xx not_active IP Right Cessation
- 1992-02-06 DE DE59206442T patent/DE59206442D1/de not_active Expired - Fee Related
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/da active
- 1992-02-06 AT AT92810085T patent/ATE138805T1/de not_active IP Right Cessation
- 1992-02-06 EP EP92810085A patent/EP0499586B1/de not_active Expired - Lifetime
- 1992-02-06 ES ES92810085T patent/ES2087497T3/es not_active Expired - Lifetime
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 MX MX9200620A patent/MX9200620A/es not_active IP Right Cessation
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/ko active IP Right Grant
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-14 NO NO920591A patent/NO179358C/no unknown
- 1992-02-14 ZA ZA921091A patent/ZA921091B/xx unknown
- 1992-02-14 JP JP4028252A patent/JPH0570352A/ja active Pending
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
-
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2061015A1 (en) | 1992-08-16 |
IL100889A0 (en) | 1992-11-15 |
IE920486A1 (en) | 1992-08-26 |
DE59206442D1 (de) | 1996-07-11 |
IL100889A (en) | 1997-03-18 |
ATE138805T1 (de) | 1996-06-15 |
ES2087497T3 (es) | 1996-07-16 |
EP0499586A1 (de) | 1992-08-19 |
MX9200620A (es) | 1992-08-01 |
NO920591D0 (no) | 1992-02-14 |
KR920016098A (ko) | 1992-09-24 |
NZ241608A (en) | 1997-06-24 |
ZA921091B (en) | 1992-09-30 |
EP0499586B1 (de) | 1996-06-05 |
NO179358B (no) | 1996-06-17 |
NO920591L (no) | 1992-08-17 |
JPH0570352A (ja) | 1993-03-23 |
DK0499586T3 (da) | 1996-06-24 |
AU1087792A (en) | 1992-08-20 |
NO179358C (no) | 1996-09-25 |
IE74906B1 (en) | 1997-08-13 |
AU655227B2 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0574313T3 (da) | 1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme | |
GR3035479T3 (en) | Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines. | |
ES8705387A1 (es) | Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida | |
EG20218A (en) | Process for preparing of substituted 3 aminoquinuclidines | |
HK1002898A1 (en) | Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1benzopyranes | |
HUT67028A (en) | Indole derivatives, pharmeceutical compositions comprising them and process for their production | |
CA2107552A1 (en) | Use of deprenyl to maintain, prevent loss, or recover nerve cell function | |
NO980923L (no) | Optisk aktivt fenylpyrimidin-derivat som analgetisk middel | |
IL113411A (en) | Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition | |
GR3020155T3 (en) | Substituted benzofuranyl-piperidine as nootropic | |
ES2081834T3 (es) | Pirrolidin-2-onas 4-metil y 4-etil sustituidas. | |
NZ233618A (en) | Optionally heterocyclic substituted pyrrolidone derivatives and pharmaceutical compositions | |
HUT61469A (en) | Process for producing pharmaceutical composition with nervous system effects |